Score Breakdown
Dilution Forecast
Market Data
Source-Backed Evidence Depth
This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.
| Field | Current Value | Basis |
|---|---|---|
| DilutionScore | 26/100 | DilutionWatch score record |
| Shares Outstanding | 4.55M | Verified float table or market cache |
| Public Float | 3.53M | Verified float table or market cache |
| Market Cap | $37.51M | Market data cache |
| Cash Runway | Not applicable / unavailable | DilutionWatch score inputs |
| Shelf Capacity | $7.50M | SEC-derived dilution fields |
| ATM Capacity | None in current score inputs | SEC-derived dilution fields |
| Outstanding Warrants | None in current score inputs | SEC-derived dilution fields |
Recent source-backed SEC insight records available on this page: 6.
Recent SEC source mix: 4 4, EFFECT 1, XBRL 1.
The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.
Institutional Holdings
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Recent SEC Activity
Recent News
Factual HBIO Dilution Snapshot
Harvard Bioscience, Inc. (HBIO) has a DilutionScore of 26/100, rated Medium dilution risk. Score date: October 13, 2026.
- Stored shelf registration capacity: $7.5M.
- Recent SEC activity tracked for HBIO: 4 on 2026-03-23; 4 on 2026-03-18; 4 on 2026-03-18.
- Score coverage note: Cash Runway is marked not applicable or unavailable while debt exceeds cash in stored market data; do not read the overall score as a complete balance-sheet risk assessment.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
DilutionScore History — Last 90 Days
HBIO's DilutionScore is currently 26/100 (Medium risk), with 1 score change tracked over 89 days. The score deteriorated from 31/100 (Medium risk).
| Period | Score | Risk Level | Duration |
|---|---|---|---|
| Oct 11 – Oct 13, 2026 | 26/100 | MEDIUM | 3 days |
| Jul 16 – Oct 10, 2026 | 31/100 | MEDIUM | 86 days |
Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.
Share Dilution History
HBIO shares outstanding have decreased 89.8% from 44.18M (Mar 2026) to 4.51M (May 2026). Each increase represents potential dilution to existing shareholders.
| Date | Shares Outstanding | Public Float | Change |
|---|---|---|---|
| May 26, 2026 | 4.51M | 3.53M | ▲ 0.83% |
| May 21, 2026 | 4.51M | 3.50M | ▲ 0.02% |
| May 03, 2026 | 4.51M | 3.50M | ▲ 0.28% |
| May 01, 2026 | 4.51M | 3.49M | ▲ 0.59% |
| Apr 24, 2026 | 4.51M | 3.47M | ▲ 0.23% |
| Apr 18, 2026 | 4.47M | 3.46M | ▼ 0.15% |
| Apr 07, 2026 | 4.47M | 3.47M | ▲ 0.32% |
| Mar 27, 2026 | 4.47M | 3.46M | ▲ 5.37% |
| Mar 26, 2026 | 4.47M | 3.28M | ▼ 2.26% |
| Mar 22, 2026 | 44.18M | 3.36M | ▼ 1.57% |
| Mar 19, 2026 | 44.18M | 3.41M | ▼ 2.77% |
| Mar 16, 2026 | 44.18M | 3.51M | ▼ 90.00% |
Share counts sourced from verified regulatory filings. Increases indicate dilution events.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:
Score Coverage Note
- Cash Runway is marked not applicable or unavailable while debt exceeds cash in stored market data; do not read the overall score as a complete balance-sheet risk assessment.
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.